Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Reiterated by Cantor Fitzgerald
Cantor Fitzgerald reissued their overweight rating on shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) in a research note published on Tuesday morning, Benzinga reports. Cantor Fitzgerald currently has a $380.00 price objective on the pharmaceutical company’s stock. A number of other brokerages also recently issued reports on VRTX. HC Wainwright raised their price target […]
More Stories
Russia Will Help China Advance Submarine Technology, US Indo-Pacific Commander Says
By Frank Fang In return for China’s support during its war on Ukraine, Russia will likely assist Beijing to advance...
Financial Contrast: Carnival Co. & (NYSE:CUK) versus Viking (NYSE:VIK)
Viking (NYSE:VIK – Get Free Report) and Carnival Co. & (NYSE:CUK – Get Free Report) are both transportation companies, but...
Centaurus Financial Inc. Lowers Stock Holdings in iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH)
Centaurus Financial Inc. cut its stake in shares of iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH – Free Report) by 2.5%...
PepsiCo, Inc. (NASDAQ:PEP) Shares Purchased by Summit Trail Advisors LLC
Summit Trail Advisors LLC increased its position in shares of PepsiCo, Inc. (NASDAQ:PEP – Free Report) by 18.3% during the...
Costco Wholesale Co. (NASDAQ:COST) Shares Acquired by Daiwa Securities Group Inc.
Daiwa Securities Group Inc. boosted its stake in Costco Wholesale Co. (NASDAQ:COST – Free Report) by 19.0% in the third...
SevenBridge Financial Group LLC Buys 335 Shares of Chevron Co. (NYSE:CVX)
SevenBridge Financial Group LLC grew its stake in Chevron Co. (NYSE:CVX – Free Report) by 3.3% in the third quarter,...